Circ_SMAD4 facilitated GC tumorigenesis by activating CTNNB1-dependent Wnt/beta-catenin pathway. Hopefully, the findings could provide new clues for improving GC prognosis and treatment.
Circ_SMAD4 promotes gastric carcinogenesis by activating wnt/beta-catenin pathway.